In the second of two Q&As with R&D colleagues, SAS' Udo Sglavo provides a window into how we approach drug-development challenges with machine learning.
A note from Udo Sglavo: At SAS, what we deliver to our customers is a product of creative minds thinking differently, challenging the norm, taking risks, and learning from trial and error (The greatest teacher, failure is). For the return of World Creativity & Innovation Week, we want to share
In a Q&A with SAS' Udo Sglavo, Xilong Chen of SAS parses the work of 2021 Nobel Prize winners for Economics.
